NO20065297L - Anvendelse av GPCR54 ligander til behandling av infertilitet - Google Patents

Anvendelse av GPCR54 ligander til behandling av infertilitet

Info

Publication number
NO20065297L
NO20065297L NO20065297A NO20065297A NO20065297L NO 20065297 L NO20065297 L NO 20065297L NO 20065297 A NO20065297 A NO 20065297A NO 20065297 A NO20065297 A NO 20065297A NO 20065297 L NO20065297 L NO 20065297L
Authority
NO
Norway
Prior art keywords
gpcr54
ligands
treat infertility
infertility
treat
Prior art date
Application number
NO20065297A
Other languages
English (en)
Inventor
Robert K Campbell
Xuliang Jiang
Shoji Nagatani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20065297L publication Critical patent/NO20065297L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Den foreliggende oppfinnelsen er rettet mot fremgangsmåter og sammensetninger for behandlingen av infertilitet.
NO20065297A 2004-04-23 2006-11-17 Anvendelse av GPCR54 ligander til behandling av infertilitet NO20065297L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56475604P 2004-04-23 2004-04-23
PCT/US2005/013339 WO2005117939A2 (en) 2004-04-23 2005-04-19 Use of gpcr54 ligands for the treatment of infertility

Publications (1)

Publication Number Publication Date
NO20065297L true NO20065297L (no) 2006-11-17

Family

ID=35463344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065297A NO20065297L (no) 2004-04-23 2006-11-17 Anvendelse av GPCR54 ligander til behandling av infertilitet

Country Status (7)

Country Link
EP (1) EP1750513A4 (no)
JP (1) JP2007533748A (no)
AU (1) AU2005249373A1 (no)
CA (1) CA2562676A1 (no)
IL (1) IL178795A0 (no)
NO (1) NO20065297L (no)
WO (1) WO2005117939A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091567A1 (es) 2004-06-25 2009-11-03 Takeda Pharmaceutical Derivados de metastina en el tratamiento del cancer
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
WO2009039996A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
GB0719592D0 (en) 2007-10-08 2007-11-14 Medical Res Council Compound, use and method
DK2314609T3 (en) * 2008-07-30 2017-03-13 Takeda Pharmaceuticals Co METASTIN DERIVATIVES AND USE THEREOF
WO2010033224A1 (en) * 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of kiss1 peptides
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9127038B2 (en) 2011-08-04 2015-09-08 Merck Sharp & Dohme Corp. Kisspeptide-pentasaccharide conjugates
WO2013142408A1 (en) * 2012-03-20 2013-09-26 Monell Chemical Senses Center Method of modifying fertility
FR3001455B1 (fr) * 2013-01-31 2017-10-06 Agronomique Inst Nat Rech Composes agonistes du recepteur kiss1r et leur utilisation pour induire l'ovulation chez les mammiferes
TW201605907A (zh) * 2014-08-12 2016-02-16 國立臺灣大學 一種調控精子授精能力短鏈胜肽之提高體外人工授精成功率之用途
MA46353A (fr) * 2016-09-30 2019-08-07 Myovant Sciences Gmbh Méthodes de traitement de l'infertilité féminine
CN109125307B (zh) * 2018-09-03 2021-05-07 河南牧翔动物药业有限公司 一种克罗米酚-多肽复合物、药物制剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577323B1 (en) * 2002-12-26 2013-07-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
WO2004080479A1 (ja) * 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤

Also Published As

Publication number Publication date
EP1750513A4 (en) 2009-07-22
IL178795A0 (en) 2007-03-08
AU2005249373A1 (en) 2005-12-15
WO2005117939A9 (en) 2006-04-20
JP2007533748A (ja) 2007-11-22
WO2005117939A3 (en) 2006-06-01
EP1750513A2 (en) 2007-02-14
CA2562676A1 (en) 2005-12-15
WO2005117939A2 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20065297L (no) Anvendelse av GPCR54 ligander til behandling av infertilitet
NO20092637L (no) Fremgangsmater for behandling
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
DE602005026508D1 (de) Monozyklische heterozyklen als kinase-hemmer
ATE464323T1 (de) Zusammensetzungen und verfahren für die tumor- diagnose und behandlung
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
TW200605886A (en) Indazoles useful in treating cardiovascular diseases
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
EA200700225A1 (ru) Аналоги тетрапептида
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201070247A1 (ru) Ингибиторы протеасом
DE602005009748D1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
NO20065251L (no) Anvendelse av peptidiske forbindelser for profilakse og behandling av kronisk hodepine
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
ATE432279T1 (de) Tricyclische delta-opioid-modulatoren
NO20075764L (no) Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
NO20093536L (no) Kombinasjonsterapi ved kreftbehandling som omfatter vinflunin og trastuzumab

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application